Oil prices still don't reflect the one-million-barrel loss due to the Iran War: ANZ
ANZ's Daniel Hynes says a dramatic drawdown in global crude inventories will finally push markets to…
Security division contract awards from TSA, CBP, and international aviation authorities (typically $50M-$300M multi-year deals)
Backlog growth and conversion rates, particularly turnkey security screening projects at international airports
Service contract renewal rates and attach rates on installed equipment base (drives recurring revenue visibility)
Healthcare division recovery post-pandemic as elective procedures normalize and hospital capex budgets expand
moderate - Security division has 60-70% government/quasi-government exposure providing stability through cycles, but timing of budget appropriations and procurement cycles creates lumpiness. Healthcare division is moderately cyclical, tied to hospital capital budgets which compress during recessions. International infrastructure spending (airports, ports) correlates with GDP growth in emerging markets. Overall revenue is less cyclical than pure industrial companies due to security/compliance mandates.
Rising rates create modest headwinds through two channels: (1) government customers may delay large capital projects when financing costs increase, particularly international airport authorities funding multi-year buildouts, and (2) higher discount rates compress valuation multiples for growth-oriented hardware companies. However, Security division's recurring service revenue (30-40% of segment sales) provides some insulation. The company's moderate debt load ($525M net debt) sees interest expense increase with rate hikes, though 3.15x current ratio provides liquidity buffer.
Government budget volatility: 60-70% revenue exposure to government/quasi-government entities means appropriations delays, sequestration, or shifting security priorities directly impact order flow
Technological disruption in screening: AI-enabled threat detection, alternative scanning technologies (millimeter wave, computed tomography) could obsolete current product lines if company fails to innovate
Regulatory changes: TSA/international aviation authority certification requirements can shift, requiring costly re-engineering or creating openings for competitors with newer technologies
growth - Company attracts growth investors seeking 10-15% revenue CAGR from security infrastructure buildout, with improving margins as service mix increases. The recurring revenue component and government contract visibility appeal to quality-focused growth managers. Not a value play given 19.4x EV/EBITDA premium to industrials. Limited dividend (likely <1% yield) means income investors avoid. Recent 23.8% one-year return and 18% EPS growth attract momentum players during contract award cycles.
Trend
+6.7% vs SMA 50 · +29.5% vs SMA 200
Momentum
Distribution pattern detected. More selling days than accumulation over the past 20 sessions. Not a conducive environment for a squeeze.
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2023 | $1.2B $1.2B–$1.3B | — | $6.09 | — | ±1% | Low1 |
FY2024 | $1.5B $1.5B–$1.5B | ▲ +22.1% | $8.09 | ▲ +32.7% | ±0% | Moderate3 |
FY2025 | $1.7B $1.7B–$1.7B | ▲ +11.8% | $9.31 | ▲ +15.1% | ±1% | High5 |
ANZ's Daniel Hynes says a dramatic drawdown in global crude inventories will finally push markets to…
creating solutions for a safer and healthier world. osi systems inc. is a diversified global developer, manufacturer and seller of security and inspection products, medical devices, and optoelectronic-based components, as well as a provider of engineering and manufacturing services. the company has more than 30 years of experience in electronics engineering and manufacturing and employs over 3,000 people through offices and production facilities located in more than a dozen countries. our singular focus is to help security experts, clinical professionals and high-tech developers solve real-world problems and issues. rapiscan systems- one company - total security in a world where effective security screening is more important than ever, rapiscan systems is the global leader. with over 70,000 systems installed in over 100 countries, our products stand for outstanding threat detection, proven reliability and unsurpassed value. spacelabs healthcare- connecting innovation with care. with pr
| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
OSIS◀ | $282.50 | -1.54% | $4.7B | 30.9 | +1133.4% | 873.5% | 1500 |
| $198.45 | -0.56% | $4.8T | 40.2 | +6547.4% | 5560.3% | 1495 | |
| $280.25 | +3.28% | $4.1T | 33.6 | +642.6% | 2691.5% | 1494 | |
| $414.19 | +1.57% | $3.1T | 24.6 | +1493.2% | 3614.6% | 1477 | |
| $421.28 | +0.92% | $2.0T | 80.0 | +2387.4% | 3619.8% | 1504 | |
| $542.21 | +4.84% | $611.5B | 25.3 | +4885.1% | 2284.5% | 1534 | |
| $360.54 | +1.71% | $587.8B | 135.6 | +3433.8% | 1251.5% | 1517 | |
| Sector avg | — | +1.46% | — | 52.9 | +2931.8% | 2842.2% | 1503 |